Organon & Co. Files Q1 2025 10-Q

Ticker: OGN · Form: 10-Q · Filed: May 2, 2025 · CIK: 1821825

Organon & CO. 10-Q Filing Summary
FieldDetail
CompanyOrganon & CO. (OGN)
Form Type10-Q
Filed DateMay 2, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, pharmaceuticals

TL;DR

Organon's Q1 2025 10-Q is in. Check financials.

AI Summary

Organon & Co. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and business segments are presented, reflecting the company's ongoing activities in the pharmaceutical sector.

Why It Matters

This filing provides investors and analysts with the latest financial health and operational performance of Organon & Co., crucial for understanding its market position and future prospects.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20250331, indicating the period ending March 31, 2025.

When was this 10-Q filed with the SEC?

This 10-Q was filed on 20250502.

What is Organon & Co.'s primary business classification?

Organon & Co. is classified under Pharmaceutical Preparations [2834].

What is the company's fiscal year end?

Organon & Co.'s fiscal year ends on 1231.

Where is Organon & Co. located?

Organon & Co. is located at 30 Hudson Street, FL 33, Jersey City, NJ 07302.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 2, 2025 regarding Organon & Co. (OGN).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing